The U.S. Food and Drug Administration has approved Regeneron’s gene therapy for a rare genetic form of deafness, the company said on Thursday.
Reuters Health Information
Source link : https://www.medscape.com/s/viewarticle/regeneron-wins-fda-approval-first-gene-therapy-genetic-2026a1000cye?src=rss
Author :
Publish date : 2026-04-23 16:44:00
Copyright for syndicated content belongs to the linked Source.